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The blaNDM-1 gene encodes a carbapenemase that confers resistance to almost all -lactams, including last-resort carbapenems.
This is increasingly reported worldwide in nosocomial and community-acquired Gram-negative bacteria. Acinetobacter bau-
mannii is an important opportunistic pathogen that is considered an intermediate reservoir for the blaNDM-1 gene. In this spe-
cies, the blaNDM-1 gene is located within the Tn125 composite transposon. The mechanism driving the mobility of Tn125 has not
yet been elucidated. Here we experimentally demonstrated the transposition of Tn125 in A. baumannii. Systematic 3-bp dupli-
cation of the target site, being the signature of transposition, was evidenced. The target site consensus sequence for Tn125 trans-
position was found to be GC enriched at the duplicated 3 bp and AT rich in the vicinity. Transposition frequency was not inﬂu-
enced by temperature changes or by exposure to subinhibitory concentrations of various antibiotics. This work is the ﬁrst direct
evidence of the functionality of a composite transposon in A. baumannii. It provides a mechanistic clue for the dissemination of
the blaNDM-1 gene in Acinetobacter spp. and subsequently among Enterobacteriaceae.
Carbapenemases are enzymes hydrolyzing most -lactams, in-cluding penicillins, cephalosporins, and carbapenems. Dur-
ing the last decade, they have been increasingly reported world-
wide in Acinetobacter baumannii, Pseudomonas aeruginosa, and
Enterobacteriaceae. The spread of carbapenemases is of utmost
importance for medicine, since carbapenems are last-resort anti-
biotics for treating the most severe and hospital-acquired infec-
tions. The class B New Delhi metallo--lactamase (NDM-1) is
a broad-spectrum -lactamase, hydrolyzing penicillins, ceph-
alosporins, and carbapenems (1). NDM-1 was ﬁrst identiﬁed in
a Klebsiella pneumoniae isolate from a patient previously hospi-
talized in India in 2008 (2). Since then, it has been foundmostly
in Enterobacteriaceae and A. baumannii and to a lesser extend in
P. aeruginosa (1, 3). The origin of the blaNDM-1 resistance gene
and the mechanism(s) driving its mobility remains unknown.
However, a current hypothesis suggests that the blaNDM-1 gene
originates froman environmental bacterial progenitor species and
that A. baumannii is an intermediate reservoir for the blaNDM-1
gene (4).
A. baumannii is an opportunistic human pathogen and a com-
mon cause of sepsis, pneumonia, urinary tract infection, and pri-
mary bacteremia.Multidrug-resistantA. baumannii isolates are of
great concern (5, 6). In Acinetobacter spp., the blaNDM-1 gene is
embedded in transposon Tn125 (4, 7, 8). Tn125 is a 10,099-bp
composite transposon bracketed by two copies of the insertion
sequence (IS) ISAba125 orientated in the same direction (Fig. 1A)
(4, 7, 8). The 1,087-bp ISAba125 element belongs to the IS30 fam-
ily and encodes a 322-amino-acid-long DDE-type transposase
surrounded by imperfect terminal inverted repeat sequences (IRR
[inverted repeat right] and IRL [inverted repeat left], sharing
20/26 nucleotide identity) (9, 10). The bleMBL gene, which encodes
a 121-amino-acid-long protein conferring resistance to bleomy-
cin, a glycopeptide antibiotic used as an antitumor agent, is lo-
cated downstream of the blaNDM-1 gene (11). In addition, Tn125
comprises six genes encoding putative proteins (iso, tat, dct, groES,
groEL, and pac [a truncated phospholipid acetyltransferase
gene]), the ISCR21 element, and the putative oriIS sequence that
deﬁnes the origin of replication of ISCR21 (7, 8). ISCR elements
are peculiar ISs belonging to the IS91 family, likely mobilizing
genes located at their left-hand extremity by a rolling-circle trans-
position process (12, 13).
Current observations suggest that the blaNDM-1 gene originates
from an unknown environmental bacterial progenitor species
and is integrated into the chromosome of Acinetobacter spp. The
blaNDM-1-bearing Tn125 transposon was likely subsequently built
from such Acinetobacter spp. and then transferred onto broad-
host-range plasmids, followed by horizontal transfer toEnterobac-
teriaceae and P. aeruginosa. This hypothesis is supported by a se-
ries of genetic features (4, 5), as follows. (i) The blaNDM-1 gene
displays a higher GC percentage (62%) than that of the genome of
Acinetobacter spp. (38% to 42%), arguing in favor of a phyloge-
netic distance between the progenitor species and Acinetobacter
spp. (ii) ISCR21mayhavemobilized a fragment encompassing the
blaNDM-1 gene that displays a similar GC percentage from an un-
knownbacterial progenitor. (iii) ISAba125has also been identiﬁed
in Acinetobacter species isolates without physical association with
the blaNDM-1 gene and shows a low GC content of 37%, consistent
with a possible Acinetobacter species origin (4, 5).
A critical step in the dissemination process of the blaNDM-1
gene is the mobility of the Tn125 transposon in Acinetobacter spp.
According to its genetic structure, it was presumed that Tn125 can
move through transposition. Transposition is a catalytic process,
driven by an element-speciﬁc transposase. During this process,
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the transposase generates a short direct repeat ﬂanking the trans-
poson in the target DNA, corresponding to a signature of the
transposition event (10). Alternative mechanisms for Tn125
transfer might involve nonhomologous recombination or cointe-
gration. Here, we show that the Tn125 transposon can efﬁciently
transpose in A. baumannii and that the transposition frequency is
not inﬂuenced by temperature changes or antibiotic pressure.
MATERIALS AND METHODS
Strains. Transposition experiments were performed in A. baumannii
CIP70.10 and Ab17978 (recA::Km) (14) reference strains. Plasmids were
constructed in Escherichia coli TOP10 (Invitrogen).
Plasmid construction.For pTOPO-Tn125, the Tn125 transposonwas
ampliﬁed from A. baumannii strain JH (8) together with 98 bp and 99 bp
of the ﬂanking genomic sequences present in upstream and downstream
Tn125, respectively, with primers JHorfTn125-HindIII-F (5=-gatgat
aagcttTCAGCAATAAATTTGTCACCAGC-3=) and JHorfTn125-XbaI-R
(5=-gatgattctagaCAAGCTGCTCAAGTTAAAGATCG-3=) (the HindIII
and XbaI restriction sites are underlined, and the uppercase letters
correspond to the open reading frame [ORF] identiﬁed in strain JH).
This amplicon was subcloned into the HindIII and XbaI restriction
sites of the pCR-BluntII-TOPO plasmid (Invitrogen). The integrity of
both ISAba125 elements and of blaNDM-1 was conﬁrmed by sequenc-
ing. pTOPO-zeodel-Tn125 was derived from pTOPO-Tn125, in which a
frameshift in the zeocin resistance gene was generated by digestion at the
unique FseI site, blunting, and self-ligation. The resulting zeocin resis-
tance protein lacks the 32 C-terminal amino acids. For the pTOPO-shut-
tle-Tn125 plasmid, the A. baumannii-speciﬁc origin of replication was
ampliﬁed from pWH1266 (a kind gift from P. Higgins) and subcloned
into pTOPO-Tn125 between the BsrGI andHindIII restriction sites. Plas-
mid pTOPO-shuttle-Tn125 replicates in E. coli, from which it can be
selected with 50 g/ml zeocin, 100 g/ml ampicillin, 25 g/ml kanamy-
cin, or 0.5 g/ml imipenem (IPM), in A. baumannii CIP70.10, from
which it can be selected with 25g/ml kanamycin, 200g/ml zeocin, or 1
g/ml IPM, and ﬁnally inA. baumanniiAb17978 recA::Km, fromwhich it
can be selectedwith 10g/ml zeocin or 1g/ml IPM. Full sequences of the
Tn125 plasmids are available upon request.
Transposition assays. One-hundred-nanogram amounts of pTOPO-
Tn125 or pTOPO-zeodel-Tn125 suicide plasmids were electroporated
into 25 l of electrocompetent A. baumannii cells with a MicroPulser
(Bio-Rad). The bacteria were resuspended in 2 ml LB and incubated for
1 h 30min at 37°Cwith agitation. A total of 100l was plated onto LB agar
plates supplemented with 1 g/ml IPM to select the transposition events.
The transformation efﬁciency was determined with the highly similar
pTOPO-shuttle-Tn125 plasmid (replicating in A. baumannii), which was
electroporated and processed in parallel to the suicide plasmids. The
transposition frequencies were calculated by dividing the number of
transposition events by the number of transformed cells. Experiments
were done in triplicate. The same procedure was used to address the effect
antibiotics has on transposition, but cells were incubated for 3 h at 37°C
after electroporationwith the following antibiotics: the glycopeptide bleo-
mycin (1 g/ml and 5 g/ml) (Molekula) or zeocin (4 g/ml and 8 g/
ml), the ﬂuoroquinolone ciproﬂoxacin (0.05g/ml and 1g/ml) (Sigma-
Aldrich), the aminoglycoside kanamycin (1.5 g/ml and 3 g/ml) (Roth;
ThermoFisher Scientiﬁc), and the carbapenem imipenem (0.125 g/ml
and 0.25 g/ml) (Mylan). The MIC of bleomycin for Tn125-containing
CIP70.10 was 10 g/ml, while it was1 g/ml for the parental CIP70.10
strain.
Molecular characterization of transposition events. The presence of
the full-length Tn125was conﬁrmed by the ampliﬁcation in 5= of a 925-bp
fragment spanning from ISAba125 to blaNDM-1 with primers 125-F
(5=-ACACCATTAGAGAAATTTGC-3=) andNDM-R (5=-CGGAATGGC
TCATCACGATC-3=) and in 3= of a 1,326-bp fragment spanning from
pac to ISAba125 with primers dpac-F (5=-CAACTGTGAGTCCTTTAC
TGAC-3=) and 125-R (5=-GCAAATTTCTCTAATGGTGT-3=). The inte-
gration sites of the transposition events were characterized by shotgun
cloning. Total genomic DNA was digested with EcoRV and ligated into
the EcoRV-digested and dephosphorylated pBSKS-kanR vector. The li-
braries were electroporated into E. coli TOP10 and plated onto LB agar
containing 1 mg/liter IPM to select for blaNDM-1-positive clones, which
were sequenced with the primer IS125tpase_NORF-R (5=-CTCACGATA
FIG 1 Transposition of Tn125. (A) Schematic representation of transposon Tn125. The total size is 10,099 bp. The ORFs are represented by arrows, and the
lengths are to scale. The two ISAba125 elements bracketing Tn125 are indicated in green, each with the transposase (tnp) gene and the IRL and IRR inverted
repeats. The blaNDM-1 gene is in red, the bleMBL gene is in blue, and the 7 other ORFs are in dark gray; the ISCR21 and the oriIS (circle) are in light gray. The GC
content (%) for each of the following fragments is indicated: 37% for each ISAba125 (nucleotides 1 to 1087 and 9013 to 10099), 65% for the sequence
encompassing blaNDM-1 to oriIS, and 32% for pac. (B) Characterization of four Tn125 transposition events in A. baumannii CIP70.10 and Ab17978 (recA
mutant) strains. The duplicated 3-bp target sites are underlined. The surrounding 50 nucleotides, upstream and downstream of each transposon insertion, are
shown. In A. baumannii CIP70.10, transposon Tn125 transposed between ORFs designated No1 (encoding proteins deposited under accession no. CRL92855.1
and CRL92856.1) or an ORF designated No2 (encoding an outer membrane protein A precursor [accession no. CRL95910.1); in A. baumannii Ab17978 (recA
mutant), transposon Tn125 transposed in theORF designatedNo1 (encoding a hypothetical protein [accession no. AKQ26110.1]) or in theORF designatedNo2
(encoding a CinA-like protein [accession no. KNZ37258.1]).
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GATCGTACTAGG-3=) to identify the genomic sequence upstream of
Tn125. For each transposition event, a primer was designed to amplify a
fragment spanning from the 3= end of Tn125 to the genomic sequence
downstreamof Tn125. These PCR ampliconswere sequencedwith primer
IS125tpase-CORF-F (5=-CATGTCACTGAATACTCGTCC-3=).
Determination of the AT and GC contents and pictogram of the
target site consensus. For the 27 transposition events characterized, the
relative frequencies of eachA andT, andG andC, for the region extending
from 50 nucleotides upstream to 50 nucleotides downstream from the
duplicated 3-bp target site were calculated and plotted onto a graph. The
pictures of the relative frequencies of the bases at each position were
generated with the Pictogram program (http://genes.mit.edu/pictogram
.html).
Detection of ISAba125 in Acinetobacter species strains. Strains were
screened by PCR with primers Tn125-F (5=-TGTATATTTCTGTGAC
CCAC-3=) and Tn125-R (5=-GAAGGCGAATTCAAACATGAGGTGC-3=).
A 255-bp product was ampliﬁed in the presence of ISAba125.
RESULTS
Transposition of Tn125 in A. baumannii. To address the trans-
position of Tn125 in A. baumannii, the suicide plasmid pTOPO-
Tn125 was transformed as the donor for the transposon in two A.
baumannii recipient strains, CIP70.10 (recA wild type) and
Ab17978 (recA mutant) (14). The pTOPO-Tn125 plasmid con-
tains the entire Tn125 transposon, together with the ﬂanking
chromosomal sequences present in the Tn125-positive A. bau-
mannii isolate JH (98 and 99 bp upstream and downstream of the
transposon, respectively) (8). Four imipenem-resistant clones,
two in A. baumannii CIP70.10 and two in A. baumannii Ab17978,
were stepwise characterized as follows. First, they were tested for
the loss of kanamycin and zeocin resistance markers, conﬁrming
that the donor plasmid did not integrate into the genome. Second,
the presence of the full-length transposon Tn125 and the absence
of the ﬂanking sequences present in the donor plasmid were con-
ﬁrmed by PCR. Third, the genomic sequences ﬂanking Tn125
were characterized in order to map the transposition sites and
analyze the target site duplication. As shown in Fig. 1B, for each of
the four studied clones, the entire Tn125 transposed into distinct
loci of the A. baumannii chromosome. A 3-bp target site duplica-
tion was present in each case. Transposition of Tn125 conferred
resistance to cephalosporins and carbapenems, with MIC values
of ceftazidime, imipenem, andmeropenembeing256,32, and
32 g/ml, respectively.
Transposition frequencies. The transposition frequencies
measured with pTOPO-Tn125 and pTOPO-zeodel-Tn125 as do-
nors were 4.5  104 (	0.5  104) and 5.7  104 (	0.9 
104) per transformed cell, respectively (Table 1, experiment 1).
The frequencies with both donor plasmids were in the same range,
excluding the potential inﬂuence of the zeocinmarker gene, which
confers resistance to the same class of molecules (bleomycin) as
the bleMBL gene. Since the source of dissemination of the blaNDM-1
gene is likely the environment, in particularly in Asia (15, 16),
where a variety of antibiotics has been widely identiﬁed (17, 18)
andwhere temperature changesmight inﬂuence the transposition
frequency (19, 20), corresponding experiments were conducted.
Incubation for 3 h with 1 or 5 g/ml bleomycin, a glycopeptide
antibiotic used as an antitumor agent, did not inﬂuence the trans-
position rate of Tn125 (Table 1, experiment 2). Similarly, the
transposition rate was not inﬂuenced by incubation for 3 h at
different temperatures (25°C, 30°C, 37°C, or 44°C) or by the pres-
ence of subinhibitory concentrations of structurally nonrelated
antibiotics, such as ﬂuoroquinolone (ciproﬂoxacin), aminoglyco-
side (kanamycin), glycopeptide (zeocin), and carbapenem (imi-
penem) (data not shown).
Target site speciﬁcity. In order to determine a consensus tar-
get site for Tn125 transposition, 25 additional independent trans-
position events, in 25 independent isolates, were characterized in
A. baumannii CIP70.10. Among the transposition events, 19 oc-
curred within open reading frames (ORFs), 8 in direct orientation
and 11 in reverse orientation compared to the disruptedORF, and
8 outside of ORFs. For each transposition event, a systematic 3-bp
duplication of the target site was evidenced (Fig. 2A). To further
characterize the features of the target site, the surrounding
genomic sequences of the 27 transposition events were aligned,
from50bpupstreamup to 50 bpdownstreamofTn125. Themean
AT content for the regions distal to the duplicated target site, from
50 to4 bp and from
4 to
50 bp relative to it, was 72% on
both sides (Fig. 2B, upper graph). Around the duplicated target
site, the AT content increased, with 100% at positions3 and
3
and 83% to 90% at positions2,1,
1, and
2 (Fig. 2B, lower
graph). By analysis of the nucleotide composition, the3 position
was found to be predominantly an A (69%), and the
3 position
was found to be predominantly a T (72%) (Fig. 2C). At the dupli-
cated target site positions, named here c1, c2, and c3, the AT con-
tent was lower (38% to 62%) (Fig. 2B, lower graph). At c1, A, T, C,
and G were equally represented (24% to 28%), while G was un-
derrepresented at c2 (10% versus 38%, 24%, and 28% for A, T,
and C, respectively) and predominant at c3 (48% versus 21%,
17%, and 14% for A, T, and C, respectively) (Fig. 2C). Further
analysis of sequences ﬂanking 74 ISAba125 elements retrieved
fromGenBank conﬁrmed the consensus derived from the analysis
of Tn125 transposition events (Fig. 2D). In conclusion, the target
site speciﬁcity of Tn125 was driven mainly both by the 3 bp sur-
rounding the duplicated target site, being AT rich and reaching
TABLE 1 Transposition frequencies of Tn125 in A. baumannii CIP70.10
Expta Incubation drug (concn)
Transposition frequency (104)b
pTOPO-Tn125 pTOPO-zeodel-Tn125
1 None 4.5 (	0.5) 5.7 (	0.9)
2 None 11.8 (	3.0) 9.6 (	5.1)
Bleomycin (1 mg/liter) 11.4 (	2.2) 9.0 (	3.4)
Bleomycin (5 mg/liter) 7.6 (	3.9) 4.6 (	1.8)
a In experiment 1, the bacteria were incubated for 1 h 30 min at 37°C after electroporation and then plated on 1-mg/liter imipenem-containing plates. In experiment 2, the bacteria
were incubated for 3 h at 37°C with the indicated concentration of bleomycin.
b pTOPO-Tn125 or pTOPO-zeodel-Tn125 was transformed as the donor of Tn125. The transposition frequencies are expressed as the number of transposition events relative to the
number of cells transformed. Experiments were performed in triplicate. Values in parentheses are standard deviations.
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96% to 99%A or T at positions3 and
3, and by the duplicated
3-bp target site itself, which was GC enriched, with a strong bias
for nucleotide G at the position c3.
Distribution of ISAba125 in Acinetobacter spp. In order to
evaluate the distribution of ISAba125, its occurrence was evalu-
ated among 17 A. baumannii and 16 Acinetobacter species clinical
isolates. These strains were negative for the blaNDM-1 gene, and
some of them carried previously characterized resistance genes to
FIG 2 Target site preferences of Tn125. (A)Molecular characterization of 27 transposition events of Tn125 in A. baumannii CIP70.10 (two of them are the same
as in Fig. 1B). For each of them, the duplicated 3-bp target site is underlined. The surrounding 50 nucleotides upstream and downstream of the target sites are
shown. (B) The 27 transposition sites of Fig. 2Awere aligned, and the percentages of AT andGC at each position, from 50 nucleotides upstream to 50 nucleotides
downstream of the target site, are shown on the graph. The 3 bp of the duplicated target site, named here c1, c2, and c3, are highlighted by a black bar. The AT
percentages of regions spanning positions50 to4 and positions
4 to
 50 and those of the region spanning positions3 to
 3 are indicated in the upper
and lower graphs, respectively. (C) Pictogram showing the relative frequencies of each A, T, C, and G at the target site, deduced from the 27 experimental
transposition events shown in panel A. (D) Pictogram showing the relative frequencies of each A, T, C, and G at the target site, deduced from 74 ISAba125
elements retrieved from GenBank (see Table 3 for references).
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broad-spectrum-lactams. ISAba125 was detected in 21 out of 33
strains (Table 2). In addition, the locations of 74 ISAba125 ele-
ments found in genomic sequences of 8 A. baumannii strains de-
posited inGenBankweremappedwith respect to their target sites.
Half of the ISAba125 elements were located within ORFs. For 6 of
them, the IRR of ISAba125, which provides a35 box promoter
element orientated toward the ﬂanking DNA, was found in prox-
imity (less than 100 bp) of the ATG start codon of the adjacent
TABLE 2 Distribution of ISAba125 in Acinetobacter species isolates, detected by PCR
Isolate Speciesa Resistance gene(s) characterizedb ISAba125 Reference or sourcec
Rem A. baumannii None  Collection
Son A. baumannii None 
 Collection
ROU A. baumannii None  Collection
4547 A. baumannii None 
 Collection
MK8744 A. baumannii None  33
AS1 A. baumannii blaOXA-23 
 34
1279 Bahe A. baumannii blaOXA-51 oE 
 Collection
CLA-1 A. baumannii blaOXA-40 
 Collection
75510 A. baumannii blaIMP-4 
 Collection
FER A. baumannii blaOXA-23  Collection
PIN A. baumannii blaOXA-40 
 Collection
1637 A. baumannii armA  Collection
AP A. baumannii blaOXA-91, blaGES-14 
 Collection
ELF A. baumannii blaOXA-40, blaTEM-1  Collection
614 A. baumannii blaOXA-23 
 34
133 A. baumannii blaOXA-58, blaOXA-64 
 35
5179 A. baumannii blaVEB-1a, blaSCO-1 
 36
CGL-3 A. haemolyticus blaOXA-58 
 Collection
7446 A. junii blaOXA-58, blaPER-2, blaSCO-1 
 36
7368 A. lwofﬁi blaOXA-58, blaPER-2, blaSCO-1 
 36
BER A. radioresistens blaOXA-105  Collection
R864 A. lwofﬁi blaOXA-134 
 Collection
5400 A. baylyi blaPER-2, blaSCO-1 
 36
0551 A. radioresistens blaOXA-23 
 Collection
CIP103788 A. radioresistens blaOXA-23, blaOXA-103 
 Collection
CIP64.7 A. genomospecies 6 blaOXA-134 
 Collection
9905 A. johnsonii blaOXA-211 
 37
CIP64.5 A. junii None  Collection
CIP107464 A. gerneri None  Collection
CIP107468 A. bouvetii None  Collection
CIP107469 A. tandoii None  Collection
CIP107470 A. grimontii None 
 Collection
CIP107472 A. towneri None  Collection
a A. baumannii is the clinically most important species.
b blaOXA genes encode carbapenem-hydrolyzing class D oxacillinases, blaTEM-1 and blaSCO-1 encode penicillinases, blaVEB-1a and blaPER-2 encode extended-spectrum beta-
lactamases (ESBLs), blaIMP-4 and blaGES-14 encode carbapenemases, and armA encodes a 16S rRNA methylase. oE, overexpression.
c Collection, personal laboratory collection.
TABLE 3 Position of 74 ISAba125 elements with respect to genomic ORFsa
Strain Accession no.
No. of ISAba125 copies
Totalb Within ORF Between ORFs Promoter providerc Reference
NCGM 237 AP013357 26 14 12 2 38
LAC-4 CP007712 14 9 5 1 39
AbH12O-A2 CP009534 3 2 1 0 40
AB04-mff CP012006 12d 5 6 0 41
ACICU CP000863 7 2 5 2 29
BJAB0715 CP003847 8 3 5 0 30
TTHO-4 CP012608 4 2 2 0 Unpublished
TCDC-AB0715 CP002522 1 0 1 1 42
a Sequences were retrieved from 8 A. baumannii complete genome sequences deposited in GenBank.
b Number of ISAba125 copies found in each strain.
c Among ISAba125 intergenic copies, those copies where the distance between the end of the IRR (which provides a35 box promoter element) and the ATG of the following ORF
was less than 100 bp.
d Ten single ISAba125 elements and 1 composite transposon made of 2 ISAba125 copies.
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ORFs (Table 3). In conclusion, ISAba125 was detected in more
than half of the Acinetobacter species clinical isolates tested and
potentially contributed to the genetic plasticity of those strains,
either by disrupting ORFs or by potentially bringing promoter
sequences to chromosomal genes.
DISCUSSION
This study actually corresponds to the ﬁrst experimental demon-
stration of the functionality of the blaNDM-1-carrying Tn125 trans-
poson. The ability of Tn125 to transpose in A. baumannii sustains
the following model: A. baumannii is an intermediate reservoir
for the blaNDM-1 gene and may contribute to further dissemination
of the blaNDM-1 gene among species. Indeed, environmental A.
baumannii is originally likely in close contact with a still unknown
progenitor of the blaNDM-1 gene or with disseminated blaNDM-1-
positive bacteria (15). It could then transfer resistance genes to
Enterobacteriaceae in the environment or in humans.
The transposase directly inﬂuences the choice of the target site,
with a preference for GC- or AT-rich DNA domains, local DNA
structure, degree of supercoiling, replication or transcription
level, and chromosome or plasmid location (10). The target site of
Tn125 was AT rich when the 3 bp surrounding the duplicated
target site was considered, reaching 99%A and 96%T at positions
3 and
3, respectively, and was enriched in GC within the 3-bp
target site, which is duplicated upon transposition, with a strong
preference forG at c3 (Fig. 2). InA. baumannii clinical isolates, the
same features are present in the chromosomal regions ﬂanking the
Tn125 and TnaphA6 composite transposons, the most recently
identiﬁed being composed of the aphA6 aminoglycoside resis-
tance gene surrounded by two ISAba125 elements (8, 21). The
preference for AT-rich regions, previously observed for ISAba1
(22), is consistent with the Acinetobacter species origin of
ISAba125, whose genome is AT rich (58 to 62%). The frequencies
of transposition of Tn125 observed here were several orders of
magnitude higher than, for example, those of the Tn2006 compos-
ite transposon and the ISAba1 and IS1999 elements (22, 23); un-
fortunately, these values are difﬁcult to compare due to different
experimental setups.
Two ISs were previously shown to be functional for transposi-
tion in A. baumannii, namely, ISAba825 (IS982 family) (24) and
ISAba1 (IS4 family) (22, 25). Here, we experimentally demon-
strated the functionality of ISAba125 (IS30 family). Consistent
with its ability to transpose, ISAba125was described in association
with increased resistance levels to -lactams in Acinetobacter
spp., for example, through duplication of the blaOXA-58 carbapen-
emase gene (26), disruption of the carO gene encoding an outer
membrane protein acting in synergy with other resistance mech-
anisms (27), or insertion upstreamof the blaADC cephalosporinase
gene (28). In the sequenced genomes of strains listed in Table 3,
ISAba125 was found upstream of the ampC gene in strain ACICU
(29) or ﬂanking the aphA6 gene conferring resistance to amikacin
in strain BJAB0715 (30).
ISAba125 was present in more than half of the clinical isolates
tested (Table 2). In a parallel study, analysis of 131 Acinetobacter
spp. revealed that 5 strains had 1 copy, 34 strains had few (2 to
9) copies, 12 strains exhibited numerous (10) copies, and 80
strains contained no copy of ISAba125 (31). This high frequency
and high copy number of ISAba125 in Acinetobacter spp. are in-
dicative of frequent transposition events, lateral gene transfer
within Acinetobacter spp., a replicative mechanism of transposi-
tion (as shown for the IS30 family), and the capacity of ISAba125
to expand within genomes, a general feature of ISs (9). Taken
together, these characteristics are suggestive of an evolutionary
role of ISAba125 customized for Acinetobacter spp., as proposed
for ISAba1 in A. baumannii (32, 33).
This work demonstrates the ability of the blaNDM-1-carrying
Tn125 transposon to transpose in A. baumannii. It underlines the
importance of A. baumannii, which has been considered for years
as playing a minor role in medical microbiology. A. baumannii is
likely in close contact in the environment with the (still unknown)
natural progenitor of the blaNDM-1 gene andmay play a key role in
the spread of the blaNDM-1 gene to clinically relevant bacterial spe-
cies, in particular members of the Enterobacteriaceae.
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